Back to search

Selentus Science Limited

10117641

active
ltd
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)

Details

3 Castlegate, Grantham, NG31 6SF
Incorporated 11/04/2016

Compliance

Last accounts

31/12/2024

total exemption full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 11/04/2026

Due 25/04/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr John Benjamin Nichols

director · Since 11/04/2016

BIOLOGIST

BRITISH · ENGLAND · Age 64

Also on 1 other board

Mr Paul David Hayes

director · Since 09/12/2022

SURGEON

BRITISH · ENGLAND · Age 57

Also on 3 other boards

Nexanova Limited

director · Since 09/12/2022

We Are Pioneer Group Limited

director · Since 11/01/2023

John Benjamin Nichols

director · Since 11/04/2016

British · England · Age 64

Nexanova Limited

corporate director · Since 09/12/2022

Reg: 1339664 · HONG KONG, CHINA

Paul David Hayes

director · Since 09/12/2022

British · England · Age 57

We Are Pioneer Group Limited

corporate director · Since 11/01/2023

Reg: 13147337

Persons with Significant Control

Dr John Benjamin Nichols

25–50% shares
25–50% votes

British · England · Age 64

3 Castlegate, Grantham, NG31 6SF

Notified 06/04/2017

Mr James Benjamin Valentine Walker

ownership-of-shares-25-to-50-percent-as-firm
voting-rights-25-to-50-percent-as-firm

British · China · Age 55

13/F, Pico Tower, 66 Gloucester Road, Hong Kong

Notified 21/11/2018

Change History

status → active
2026-07-10

Active

type → ltd
2026-07-10

Private Limited Company

address line1 → 3 Castlegate
2026-07-10

3 CASTLEGATE

post town → Grantham
2026-07-10

GRANTHAM

CompanyRankvs 1695+ SIC 72110 peers
47

Financial strength51th percentile among SIC peers · 13/25
Employees48th percentile among SIC peers · 7/15
LiquidityCurrent ratio 0.33× · 2/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Ccm Technologies Limited
90
10Bio - Diagnostics Limited
89
1695Selentus Science Limited
47
How is this score calculated?
Financial strength13/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£303

Balance sheet strength

Cash

£35k

Cash in the bank

Net Current Assets

-£139k

Working capital

Current Assets

£69k

Current Liabilities

£208k

Fixed Assets

£6k

Debtors

£34k

1avg. employees

Balance Sheet

Intangible assets£4k
Assets less current liabilities-£133k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20240.33
20231.34
20232.13

Derived from filed accounts. Not audited figures.